Related Experiment Video
Updated: Apr 19, 2026
Using an Automated Hirschberg Test App to Evaluate Ocular Alignment
Published on: March 24, 2020
Whole-population vision screening in children aged 4-5 years to detect amblyopia
Ameenat Lola Solebo1, Phillippa M Cumberland2, Jugnoo S Rahi3
1Life Course Epidemiology and Biostatistics Section, UCL Institute of Child Health, London, UK; Ulverscroft Vision Research Group, UCL Institute of Child Health, London, UK; Moorfields Eye Hospital NHS Foundation Trust/NIHR Moorfields Biomedical Research Centre, London, UK; Institute of Ophthalmology, University College London, London, UK.
Insights
Early detection of amblyopia (lazy eye) in children is crucial for preventing vision loss. Screening at 4-5 years old offers the most benefit, while younger or older screening poses risks.
Area of Science:
- Ophthalmology
- Developmental Neuroscience
- Public Health
Background:
- Amblyopia, a common neurodevelopmental disorder, affects at least 2% of the population, potentially causing permanent vision impairment.
- Current whole-population screening programs for children under 5 exhibit significant diversity due to incomplete evidence.
- The individual-level functional impact of amblyopia is not well-defined, but its high prevalence suggests a notable population-level effect.
Purpose of the Study:
- To evaluate the optimal age for amblyopia screening in children.
- To highlight the need for evidence-based guidelines for amblyopia screening and diagnosis.
- To underscore the importance of characterizing the real-life adverse effects of amblyopia.
Main Methods:
- Review of existing literature on amblyopia screening programs and their outcomes.
- Analysis of the benefits and risks associated with screening at different childhood ages.
- Assessment of the evidence base for current screening practices.
Main Results:
- Screening children aged 4-5 years, particularly at school entry, provides the greatest benefit and promotes equitable access to treatment.
- Screening younger children increases the likelihood of false-positive results.
- Screening older children is associated with poorer outcomes for those with moderate to severe amblyopia.
Conclusions:
- Standardization of amblyopia screening and diagnosis is recommended.
- Further research is needed to fully characterize the real-life adverse effects of amblyopia.
- Evidence-based guidelines are essential for effective implementation of childhood amblyopia screening programs.
Abstract:
Amblyopia is a neurodevelopmental disorder that affects at least 2% of most populations and can lead to permanently reduced vision if not detected and treated within a specific period in childhood. Whole-population screening of children younger than 5 years is applied in many countries. The substantial diversity in existing programmes reflects their heterogeneous implementation in the absence of the complete evidence base that is now a pre-requisite for instituting screening. The functional importance of amblyopia at an individual level is unclear as data are scarce, but in view of the high prevalence the population-level effect might be notable. Screening of all children aged 4-5 years (eg, at school entry) confers most benefit and addresses inequity in access to timely treatment. Screening at younger ages is associated with increased risk of false-positive results, and at older ages with poor outcomes for children with moderate to severe amblyopia. We suggest that the real-life adverse effects of amblyopia should be characterised and screening and diagnosis should be standardised.
